Niagen Bioscience, Inc. (NAGE)
3.17
+0.06
(+1.93%)
USD |
NASDAQ |
Sep 04, 16:00
3.16
-0.01
(-0.32%)
After-Hours: 20:00
Niagen Bioscience Enterprise Value : 185.73M for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 185.73M |
| September 03, 2026 | 180.99M |
| September 02, 2026 | 185.73M |
| September 01, 2026 | 182.57M |
| August 31, 2026 | 182.57M |
| August 28, 2026 | 195.20M |
| August 27, 2026 | 188.88M |
| August 26, 2026 | 195.99M |
| August 25, 2026 | 193.62M |
| August 24, 2026 | 188.88M |
| August 21, 2026 | 188.88M |
| August 20, 2026 | 184.15M |
| August 19, 2026 | 185.73M |
| August 18, 2026 | 177.05M |
| August 17, 2026 | 175.47M |
| August 14, 2026 | 173.89M |
| August 13, 2026 | 176.26M |
| August 12, 2026 | 177.05M |
| August 11, 2026 | 178.63M |
| August 10, 2026 | 176.26M |
| August 07, 2026 | 181.78M |
| August 06, 2026 | 175.47M |
| August 05, 2026 | 169.16M |
| August 04, 2026 | 209.40M |
| August 03, 2026 | 214.13M |
| Date | Value |
|---|---|
| July 31, 2026 | 203.88M |
| July 30, 2026 | 197.56M |
| July 29, 2026 | 189.67M |
| July 28, 2026 | 195.20M |
| July 27, 2026 | 190.46M |
| July 24, 2026 | 188.88M |
| July 23, 2026 | 187.31M |
| July 22, 2026 | 203.48M |
| July 21, 2026 | 210.98M |
| July 20, 2026 | 201.51M |
| July 17, 2026 | 194.41M |
| July 16, 2026 | 203.88M |
| July 15, 2026 | 209.40M |
| July 14, 2026 | 195.20M |
| July 13, 2026 | 209.40M |
| July 10, 2026 | 203.09M |
| July 09, 2026 | 210.98M |
| July 08, 2026 | 201.51M |
| July 07, 2026 | 207.82M |
| July 06, 2026 | 211.77M |
| July 02, 2026 | 206.24M |
| July 01, 2026 | 198.35M |
| June 30, 2026 | 187.31M |
| June 29, 2026 | 198.24M |
| June 26, 2026 | 207.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cyanotech Corp. | 13.80M |
| Mannatech, Inc. | 17.73M |
| Natural Alternatives International, Inc. | 69.02M |
| USANA Health Sciences, Inc. | 152.31M |
| Nature's Sunshine Products, Inc. | 185.87M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.963M |
| Revenue (Quarterly) | 29.78M |
| Total Expenses (Quarterly) | 28.82M |
| EPS Diluted (Quarterly) | 0.0117 |
| Gross Profit Margin (Quarterly) | 64.84% |
| Profit Margin (Quarterly) | 3.23% |
| Earnings Yield | 5.93% |
| Operating Earnings Yield | 3.21% |
| Normalized Earnings Yield | 5.937 |